Women’s health biotech company Oviva Therapeutics has announced an in-licensing agreement with Massachusetts General Hospital (MGH) of a family of patents, as well as $11.5M in seed funding, to develop first-in-class therapeutics to improve healthspan, the period of life spent in good health, in women. Oviva Therapeutics addresses the vast unmet need in women’s health by expanding funding, research, and clinical development of treatments…
A couple of weeks ago Hertility took over London with its thought-provoking out-of-home campaign, but the company’s ambitions clearly aren’t limited to the UK. Today, as Hertility gears up for rapid international expansion, the company is announcing the acquisition of Netherlands-based competitor Grip. Until now, comprehensive data on women’s health hasn’t existed, but acquiring Grip will expand Hertility’s own dataset and help…
WILE, a hormonal wellness brand focused on women going through perimenopause has raised $3M in pre-seed funding and will debut nine SKUs in all Whole Foods Market doors this month. The round was led by Serena Ventures with participation from Springdale Ventures, angel investor Sara Bright and Coyote Ventures. The company was co-founded by Gwen Floyd, Corey Scholibo, and Julie Kucinski alongside…
Elix, a modern platform to deliver organic, personalized and clinically proven herbal healing formulas derived from Traditional Chinese Medicine (TCM), has seen quite some success since its launch in 2019 supporting women struggling with painful periods. Now the company, that has raised $2.7M to date, is adding a new product to its line-up: Daily Harmony, a clinical strength, natural hormone-balancing formula fortified…
Gameto, a biotechnology startup solving the problem of accelerated ovarian aging to change the trajectory of women’s health and equality, today announced that it has raised a $20M in Series A funding led by Future Ventures, with participation from Bold Capital Partners, Lux Capital, Plum Alley, TA Ventures, Overwater Ventures, Robert Nelsen and Anne Wojcicki. Gameto also raised $3M in Seed funding in March 2020 from a range of notable investors…
Carrot Fertility, the fertility healthcare and family-forming benefits provider for employers and health plans, is launching new capabilities for members to perform at-home fertility hormone and related biomarker monitoring. This custom, one-of-a-kind test kit goes beyond traditional fertility hormone tests to offer a more complete picture of fertility health, enabling earlier action and interventions from the comfort of home. The Female Fertility…
Women’s Health Pharma company and Merck spin-off Organon, has completed its recently announced acquisition of Forendo Pharma, a clinical-stage drug development company focused on novel treatments in women’s health. Forendo’s lead candidate, FOR-6219, is an investigational, potentially first-in-class oral 17β-hydroxysteroid dehydrogenase type 1 (HSD17B1) inhibitor entering Phase 2 clinical development for endometriosis. Forendo’s pipeline also includes a preclinical program targeting polycystic ovarian…
Reproductive health company Proov has raised a $9.7M Series A led by Hambrecht Ducera Growth Venture to invest in its newly launched “Complete” product. Other participants in the round include SteelSky Ventures, WCC Partners, LightShip Capital, GingerBread Capital, and Portfolia Proov is known for its PdG test and associated patented protocol, that lets women confirm ovulation quality, which pertains to when ovulation…
